ENLV, IL0011319527

Enlivex moves reverse split vote as Enlivex stock stays below USD 1.00

Published on 10/06/2026 at 12:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Shareholders vote October 16, 2026 on a 1-for-13 to 1-for-16 split. Enlivex stock stays below Nasdaq's USD 1.00 bid threshold.

ENLV, IL0011319527, Illustration mit AI erstellt.

Enlivex (IL0011319527) is seeking approval for a reverse split ranging from 1-for-13 to 1-for-16, while Enlivex stock remains below Nasdaq's USD 1.00 minimum bid requirement. According to StockTitan on October 2, 2026, Enlivex moved its extraordinary shareholder meeting to October 16, 2026.

Reverse split vote moves to October 16

The amended filing sets the meeting for October 16, 2026, with the vote scheduled for 10:00 a.m. Israel time. The record date is October 5, 2026, and the board would choose the final ratio within the proposed 1-for-13 to 1-for-16 range, according to StockTitan.

The proposal also authorizes additional reverse splits at an aggregate ratio from 1-for-2 to 1-for-1,000 over the following 12 months. Shareholder approval requires a majority of the ordinary shares represented and voting, excluding abstentions.

Nasdaq threshold remains USD 1.00

Enlivex says the first reverse split is intended to lift its share price above Nasdaq's USD 1.00 minimum bid threshold. The filing states that the shares closed below USD 1.00 on each trading day since September 10, 2026, and that Nasdaq could issue a delisting determination if the bid remains below the threshold for 30 consecutive trading days through October 21, 2026.

The company operates two stated business lines. Its investor materials describe late-stage clinical development of Allocetra for osteoarthritis and a digital asset treasury strategy centered on the Rain prediction markets protocol, according to Enlivex.

Primary quote matches yearly low

On Nasdaq, Enlivex was last at USD 0.36 on October 5, 2026 at 4:00 p.m. ET, versus a prior close of USD 0.39. The USD 0.36 quote matched the reported 52-week low, while the 52-week high was USD 27.15.